Abstract
When caring for adolescents and young women with chronic illnesses, it is important to address routine gynecologic care and your patient’s contraceptive needs to ensure her optimal health and avoid putting an unplanned pregnancy at risk for serious health effects to both the mother and/or the fetus. This chapter will review what special considerations need to be employed in routine gynecologic care for medically complex paients including Pap smear screening, STI screening, and HPV vaccination. In addition, this chapter will discuss special considerations to address your patient’s contraceptive needs. This will include how the chronic illness and the medications used to treat it interact with contraception and why it is important to consider the risk of pregnancy to your patient’s health and that of the fetus, in addition to issues of teratogenicity, thrombosis, contraceptive efficacy, continuation rates, and interactions with contraception and chronic illness medications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ACOG Practice Bulletin Number 157: cervical cancer screening and prevention. Obstet Gynecol. 2016;127(1):e1–20.
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 14 May 2016.
Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2009. Atlanta: U.S. Department of Health and Human Services; 2010.
Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338(7):423.
Klumb EM, Araújo ML Jr, Jesus GR, et al. Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression? J Clin Rheumatol. 2010;16:153.
Origoni M, Stefani C, Dell’Antonio G, et al. Cervical Human Papillomavirus in transplanted Italian women: a long-term prospective follow-up study. J Clin Virol. 2011;51(4):250–4.
Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283(8):1031.
Kane S, Khatibi B, Reddy D. Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2007;103(3):631–6.
Phipps W, Stanley H, Kohn R, Stansell J, Klausner JD. Syphilis, chlamydia, and gonorrhea screening in HIV-infected patients in primary care, San Francisco, California, 2003. AIDS Patient Care STDS. 2005;19(8):495.
CDC, Health Resources and Services Administration, National Institutes of Health, American Academy of HIV Medicine, Association of Nurses in AIDS Care, International Association of Providers of AIDS Care, the National Minority AIDS Council, and Urban Coalition for HIV/AIDS Prevention Services. Recommendations for HIV prevention with adults and adolescents with HIV in the United States, 2014. http://stacks.cdc.gov/view/cdc/26062.
Kumar D, Unger ER, Panicker G, Medvedev P, Wilson L, Humar A. Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant. 2013;13(9):2411–7. Epub 2013 Jul 9.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1.
Robinson CL, Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years – United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(4):86–7.
Guazzelli CAF, Torloni MR, Sanches TF, et al. Contraceptive counseling and use among 197 female kidney transplant recipients. Transplantation. 2008;86:669.
Medical eligibility criteria for contraceptive use. 4th ed. World Health Organization. 2015. http://www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/. Accessed 25 April 2016.
U.S. Medical Eligibility Criteria for contraceptive use, 2010: adapted from the World Health Organization medical eligibility criteria for contraceptive use. 4th ed. http://www.cdc.gov/reproductivehealth/unintendedpregnancy/usmec.htm. Accessed 25 April 2016.
Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550–8.
Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2539–49.
Choojitarom K, Verasertniyom O, Totemchokchyakarn K, et al. Lupus nephritis and Raynaud’s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies. Clin Rheumatol. 2008;27:345–51.
Wahl DG, Guillemin F, de Maistre E, et al. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus–a meta-analysis. Lupus. 1997;6:467–73.
Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med. 2016;374(9):843–85.
Steinkellner A, Chen W, Denison SE. Adherence to oral contraception in women on Category X medications. Am J Med. 2010;123(10):929.
Hatcher RA. Contraceptive technology. 20th ed. Bridging the Gap Communications; 2011.
Trussell J. Contraceptive failure in the United States. Contraception. 2011;83:397.
Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM. Continuation of reversible contraception in teenagers and young women. Obstet Gynecol. 2012;120(6):1298–305.
Suggested Educational Reading, References, and Policies
The American Congress of Obstetricians and Gynecologists. Practice Bulletin Number 157: cervical cancer screening and prevention. Obstet Gynecol. 2016;127(1):e1–20.
Medical eligibility criteria for contraceptive use. 5th Edition. World Health Organization. http://www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/.
U.S. Medical Eligibility Criteria for contraceptive use. http://www.cdc.gov/reproductivehealth/unintendedpregnancy/usmec.htm.
2015 Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. http://www.cdc.gov/std/tg2015/
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Jacobs, A.M. (2018). Gynecologic Care and Contraception in the Medically Complex Adolescent. In: Talib, H.J. (eds) Adolescent Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-66978-6_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-66978-6_22
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-66977-9
Online ISBN: 978-3-319-66978-6
eBook Packages: MedicineMedicine (R0)